Stock listing

NASDAQ:SCNI Scinai Immunotherapeutics Ltd. Stock

Follow Scinai Immunotherapeutics Ltd. into a list and get an email when it puts out news.

Share price · NASDAQ:SCNI

$0.441 USD -0.010 (-2.2%)

Close on Nov 6, 2026

Past year -95.8% · daily closes, Nov 6, 2025 – Nov 6, 2026, adjusted for splits
Day range
$0.426 – $0.490 USDNov 6, 2026
Volume
13,085 sharesNov 6, 2026
Market cap
$1.16M USDAt the close on Nov 6, 2026 · price × 2.63M shares outstanding
52-week range
$0.390 – $13.000 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
Traded on an average day
$3.52M USDMedian day 93,900 shares · last 3 months, Aug 6, 2026 – Nov 6, 2026

Daily closes

Last 3 months, Aug 6, 2026 – Nov 6, 2026 · NASDAQ:SCNI · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.441-0.010-2.2%$0.446$0.490$0.42613,085
$0.451+0.002+0.5%$0.475$0.488$0.425195,628
$0.449-0.023-4.9%$0.440$0.472$0.44013,899
$0.472-0.002-0.5%$0.462$0.494$0.39098,609
$0.474+0.002+0.5%$0.480$0.500$0.416165,098
$0.472-0.047-9.1%$0.545$0.545$0.47052,900
$0.519-0.015-2.8%$0.564$0.564$0.51043,500
$0.534+0.003+0.6%$0.536$0.551$0.50339,300
$0.531-0.011-2.0%$0.550$0.570$0.52049,600
$0.542-0.023-4.1%$0.518$0.574$0.518122,300
$0.565-0.046-7.5%$0.579$0.594$0.54536,900
$0.611+0.001+0.2%$0.569$0.642$0.569137,200
$0.610-0.071-10.4%$0.690$0.690$0.550180,900
$0.681-0.069-9.2%$0.740$0.740$0.673129,500
$0.750-0.002-0.3%$0.750$0.751$0.660109,500
$0.752-0.150-16.6%$0.833$0.900$0.732224,700
$0.902+0.022+2.5%$0.786$0.943$0.760372,400
$0.880-0.350-28.5%$0.782$0.951$0.7502,723,600
$1.230+0.070+6.0%$1.560$1.760$1.14064,095,300
$1.160-0.020-1.7%$1.180$1.200$1.10542,500
$1.180-0.030-2.5%$1.220$1.230$1.18019,200
$1.210+0.080+7.1%$1.110$1.230$1.06089,300
$1.130-0.090-7.4%$1.200$1.230$1.12039,800
$1.220-0.040-3.2%$1.263$1.290$1.22042,700
$1.260-0.070-5.3%$1.330$1.362$1.26037,600
$1.330+0.020+1.5%$1.302$1.370$1.30022,100
$1.310-0.110-7.7%$1.390$1.450$1.27042,100
$1.420+0.010+0.7%$1.360$1.420$1.32079,500
$1.410-0.060-4.1%$1.500$1.500$1.35097,500
$1.470-0.080-5.2%$1.550$1.570$1.43067,400
$1.550-0.310-16.7%$1.715$1.730$1.550119,800
$1.860-0.120-6.1%$1.910$1.939$1.810165,700
$1.980+0.070+3.7%$1.760$2.080$1.690517,400
$1.910+0.220+13.0%$1.610$1.933$1.570661,200
$1.690+0.130+8.3%$1.710$1.830$1.57016,250,700
$1.560-0.060-3.7%$1.600$1.770$1.500215,300
$1.620+0.100+6.6%$1.440$1.730$1.435406,100
$1.520-0.020-1.3%$1.430$1.560$1.430388,800
$1.540-0.900-36.9%$1.840$1.880$1.5001,430,400
$2.440+0.780+47.0%$2.330$2.670$2.21041,055,200
$1.660-0.010-0.6%$1.680$1.780$1.6513,493,700
$1.670-0.040-2.3%$1.680$1.690$1.60044,200
$1.710+0.010+0.6%$1.710$1.770$1.65067,300
$1.700-0.160-8.6%$1.750$1.840$1.65097,700
$1.860-0.090-4.6%$1.930$2.010$1.85082,500
$1.950-0.390-16.7%$2.050$2.100$1.950189,100
$2.340-0.120-4.9%$2.420$2.450$2.2601,612,000
$2.460-0.040-1.6%$2.430$2.610$2.39254,900
$2.500-0.010-0.4%$2.450$2.700$2.42024,600
$2.510-0.170-6.3%$2.700$2.980$2.33036,900
$2.680-0.190-6.6%$2.840$2.840$2.62092,200
$2.870-0.010-0.3%$2.850$3.050$2.75095,600
$2.880-0.250-8.0%$3.050$3.160$2.740136,258
$3.130-0.090-2.8%$3.250$3.250$2.872177,345
$3.220+0.280+9.5%$3.200$3.580$2.850428,394
$2.940+0.200+7.3%$2.800$3.171$2.641166,400
$2.740+0.385+16.3%$2.400$3.100$2.330173,331
$2.355+0.073+3.2%$2.300$2.424$2.20214,579
$2.282-0.143-5.9%$2.400$2.410$2.2609,321
$2.425+0.025+1.0%$2.400$2.498$2.40012,192
$2.400-0.070-2.8%$2.450$2.500$2.3086,482
$2.470+0.110+4.7%$2.365$2.470$2.3009,926
$2.360-0.153-6.1%$2.437$2.459$2.3078,269
$2.513+0.060+2.4%$2.500$2.630$2.42614,214
$2.453-0.135-5.2%$2.500$2.599$2.40620,183
$2.588+0.088+3.5%$2.250$2.600$2.15242,514

Splits

3 splits since 2022 · NASDAQ:SCNI · every price before a split is adjusted for it

DayRatioWhat
1-for-10Consolidation
1-for-10Consolidation
1-for-10Consolidation
Ticker
NASDAQ:SCNI
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Scinai Immunotherapeutics (NASDAQ:SCNI) Q2 2026 Earnings Call

    Wed, Aug 26, 2026 · 11:00 AM ET

    Watch Transcript

Latest news

Scinai Reports Significant Revenue Growth in First Nine Months of 2026 as CDMO Business Expands

Nov 5, 2026

Closed $0.451 (+0.5%) on Nov 5, 2026

Scinai CEO Updates Shareholders on CDMO Growth and Extended Runway Following Completed Financing

Oct 20, 2026

Closed $0.681 (-9.2%) on Oct 20, 2026

Scinai Immunotherapeutics Announces Closing of $4.0 Million Financing Through a Private Placement and Warrant Inducement

Oct 16, 2026

Closed $0.752 (-16.6%) on Oct 16, 2026

All Scinai Immunotherapeutics Ltd. news

Financings

  • ADSs under standby equity purchase agreement (SEPA)

    Oct 20, 2026

    Closed: US$1.67M raised

    Buyers: YA II PN, Ltd. (approximately $1.67 million in net proceeds through SEPA drawdowns)

    Closed Oct 20, 2026

  • Private placement of american Depositary Shares (or pre-funded warrants) with Series A-1 Warrants

    Oct 16, 2026

    Closed: Series A-1 Warrants to purchase up to 3,687,501 ADSs · A.G.P./Alliance Global Partners

    Dealers: A.G.P./Alliance Global Partners (lead)

    Use of proceeds: Advance current customer programs, pursue additional CDMO contracts and continue selective investment in its immunotherapy pipeline

    Closed Oct 16, 2026

  • Exercise of existing warrants for ADSs with new Series A-1 Warrants (warrant inducement)

    Oct 16, 2026

    Closed: US$1.2 a share · A.G.P./Alliance Global Partners

    Dealers: A.G.P./Alliance Global Partners (lead)

    Use of proceeds: Advance current customer programs, pursue additional CDMO contracts and continue selective investment in its immunotherapy pipeline

    Closed Oct 16, 2026

Read by 6ix AI from the company's releases

Decks

Scinai Immunotherapeutics Ltd. on 6ix

News releases
3 in the last 12 months · 3 in all · newest Nov 5, 2026 · oldest 2026
Calls
1 call with a replay · 1 with a transcript · latest Aug 26, 2026
Decks
21 decks · latest 2026

Log in to ask 6ix AI your own questions about Scinai Immunotherapeutics Ltd.